Showing results (1-10 of 35) with videos related to
Sort By:
Pageof 4
Methods in Molecular Medicine|March 1, 2006
Overview of real-time RT-PCR strategies for quantification of gene rearrangements in the myeloid malignanciesChristophe Picard, Monique Silvy, Jean GabertExpert Review of Molecular Diagnostics|June 19, 2014
Minimal residual disease testing in hematologic malignancies and solid cancerAmin Ben Lassoued, Vanessa Nivaggioni, Jean GabertLeukemia Research|October 8, 2005
Assessment of a new RNA stabilizing reagent (Tempus Blood RNA) for minimal residual disease in onco-hematology using the EAC protocolNicolas Prezeau, Monique Silvy, Jean Gabert, et al.The Journal of Molecular Diagnostics : JMD|May 31, 2012
Development of plasmid calibrators for absolute quantification of miRNAs by using real-time qPCRChristine Formisano-Tréziny, Marina de San Feliciano, Jean GabertExpert Opinion on Medical Diagnostics|March 28, 2013
Hypoxia-inducible factor-1α as prognostic markerAmin Ben Lassoued, Nathalie Beaufils, Jean-Philippe Dales, et al.Leukemia & Lymphoma|March 23, 2002
Ikaros gene expression and leukemiaCécile Tonnelle, Boris Calmels, Christine Maroc, et al.The Journal of Molecular Diagnostics : JMD|November 18, 2016
Detection of CALR and MPL Mutations in Low Allelic Burden JAK2 V617F Essential ThrombocythemiaFabrice Usseglio, Nathalie Beaufils, Anne Calleja, et al.Cancers|July 14, 2023
Impact of Next-Generation Sequencing in Diagnosis, Prognosis and Therapeutic Management of Acute Myeloid Leukemia/Myelodysplastic NeoplasmsLamia Madaci, Laure Farnault, Norman Abbou, et al.Journal of Clinical Pathology|August 13, 2010
E355G mutation appearing in a patient with e19a2 chronic myeloid leukaemia resistant to imatinibAyda Bennour, Nathalie Beaufils, Halima Sennana, et al.BMC Cancer|May 25, 2017
First case of B ALL with KMT2A-MAML2 rearrangement: a case reportEstelle Menu, Nathalie Beaufils, Fabrice Usseglio, et al.Pageof 4